bluebird bio Reports First Quarter 2023 Financial Results and Highlights Operational Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
bluebird bio (BLUE) Tops Q1 EPS by 58c
May 9, 2023 7:10 AM EDTbluebird bio (NASDAQ: BLUE) reported Q1 EPS of $0.21, $0.58 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $6.49 million.
For earnings history and earnings-related data on bluebird bio (BLUE) click here.
... More